(VIANEWS) – AMSC (AMSC.OL), ALTRI SGPS (ALTR.LS), NORSKE SKOG (NSKOG.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. AMSC (AMSC.OL)
1395% sales growth and 8.21% return on equity
AMSC ASA, through its subsidiaries, invests in maritime assets and companies in the United States. It operates one international subsea construction vessel. The company was formerly known as American Shipping Company ASA and changed its name to AMSC ASA in October 2022. AMSC ASA was incorporated in 2005 and is headquartered in Lysaker, Norway.
Earnings Per Share
As for profitability, AMSC has a trailing twelve months EPS of kr2.85.
PE Ratio
AMSC has a trailing twelve months price to earnings ratio of 9.28. Meaning, the purchaser of the share is investing kr9.28 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.21%.
Yearly Top and Bottom Value
AMSC’s stock is valued at kr26.45 at 22:20 EST, way below its 52-week low of kr34.15.
Volume
Today’s last reported volume for AMSC is 46986 which is 24.01% below its average volume of 61832.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on May 30, 2023, the estimated forward annual dividend rate is 5.28 and the estimated forward annual dividend yield is 12.8%.
More news about AMSC.
2. ALTRI SGPS (ALTR.LS)
39.3% sales growth and 18.52% return on equity
Altri, SGPS, S.A. produces and sells cellulosic fibers and energy in Portugal and internationally. The company produces pulp products for various application including production of paper, tissue, and printing and writing papers; and dissolving pulp for use of textile production. It is also involved timber commercialization; forest management; production of forest-based renewable energy, such as industrial cogeneration from black liquor and biomass; real estate activities; and production of plants in nurseries, as well as the provision of services related with forests and landscapes. The company was incorporated in 2005 and is headquartered in Porto, Portugal.
Earnings Per Share
As for profitability, ALTRI SGPS has a trailing twelve months EPS of €0.37.
PE Ratio
ALTRI SGPS has a trailing twelve months price to earnings ratio of 13.64. Meaning, the purchaser of the share is investing €13.64 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.52%.
More news about ALTRI SGPS.
3. NORSKE SKOG (NSKOG.OL)
32.1% sales growth and 8.63% return on equity
Norske Skog ASA engages in the production and sale of publication and packaging paper products in Norway, rest of Europe, North America, Australasia, Asia, and Africa. It operates in Publication paper Europe, Publication paper Australasia, and Packaging paper segments. The company offers newsprint paper products comprising standard newsprint and other papers; magazine papers, including super calendared and lightweight coated papers; and recycled containerboards. Its products are primarily used in newspapers and magazines, periodicals, catalogues, brochures, advertising materials, inserts/flyers, supplements, free-sheets, directories, direct mail, and books. Norske Skog ASA was founded in 1962 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NORSKE SKOG has a trailing twelve months EPS of kr5.72.
PE Ratio
NORSKE SKOG has a trailing twelve months price to earnings ratio of 6.11. Meaning, the purchaser of the share is investing kr6.11 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.63%.
More news about NORSKE SKOG.
4. WDP (WDP.BR)
12.5% sales growth and 4.89% return on equity
WDP develops and invests in logistics property (warehouses and offices). WDP has over 7 million m² of properties in its portfolio. This international portfolio of semi-industrial and logistics buildings is spread over about 300 sites at prime logistics hubs for storage and distribution in Belgium, France, the Netherlands, Luxembourg, Germany and Romania.
Earnings Per Share
As for profitability, WDP has a trailing twelve months EPS of €0.97.
PE Ratio
WDP has a trailing twelve months price to earnings ratio of 25.34. Meaning, the purchaser of the share is investing €25.34 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.89%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Apr 25, 2024, the estimated forward annual dividend rate is 1.12 and the estimated forward annual dividend yield is 4.6%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 17.5%, now sitting on 437.19M for the twelve trailing months.
Sales Growth
WDP’s sales growth is 14.5% for the present quarter and 12.5% for the next.
Volume
Today’s last reported volume for WDP is 74505 which is 71.87% below its average volume of 264909.
More news about WDP.
5. AZERION (AZRN.AS)
10.7% sales growth and 22.92% return on equity
Azerion Group N.V. operates a digital entertainment and media platform in the Netherlands, Germany, France, Great Britain, Ireland, Italy, other Nordic and European countries, the United States, the United Arab Emirates, and internationally. The company operates in two segments, Platform and Premium Games. Its integrated platform offers technology solutions to automate the purchase and sale of digital advertising inventory for advertisers, publishers, and game creators, as well as to develop, publish, distribute, and operate online social and casual games, and digital content. The company also operates Hawk, a digital advertising technology platform. Azerion Group N.V. was founded in 2013 and is headquartered in Schiphol-Rijk, the Netherlands.
Earnings Per Share
As for profitability, AZERION has a trailing twelve months EPS of €0.14.
PE Ratio
AZERION has a trailing twelve months price to earnings ratio of 10.36. Meaning, the purchaser of the share is investing €10.36 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.92%.
Sales Growth
AZERION’s sales growth is 6.5% for the present quarter and 10.7% for the next.
Moving Average
AZERION’s value is below its 50-day moving average of €1.50 and way under its 200-day moving average of €1.66.
Yearly Top and Bottom Value
AZERION’s stock is valued at €1.45 at 22:20 EST, way under its 52-week high of €2.43 and way higher than its 52-week low of €1.27.
Volume
Today’s last reported volume for AZERION is 31159 which is 0.16% above its average volume of 31108.
More news about AZERION.
6. SANOFI (SAN.PA)
7.4% sales growth and 5.82% return on equity
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €4.3.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.82%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 7.5%, now sitting on 47.08B for the twelve trailing months.
More news about SANOFI.
7. SPBK1 ØSTFOLD AKE (SOAG.OL)
7.3% sales growth and 12.1% return on equity
SpareBank 1 Østfold Akershus, a savings bank, provides various banking products and services. The company offers savings, operating, tax deduction, deposit, placement, and currency accounts; and savings and investment products. It also provides consumer, construction, repayment, boat, motorcycle, and car loans; operating credit products; bank guarantees; operating credit for agriculture; mortgage products; leasing and factoring services. In addition, the company offers various insurance products, such as vehicle, house and travel, personal, animal, liability, work machine, interruption, condominium, cyber, movable property, commercial building, project, transport, crime, bus, group life, health, leisure accident, occupational injury, accident insurance children, and sick pay insurance products; and pension products. Further, it provides credit, municipal payment, and other bank cards; payment terminal, debt collection, and document collection services; bonds, forwards, and currency options; invoice automatic, eGiro/Cremul, KID invoice, and OCR and eGiro payment services; and mobile and online banking services. SpareBank 1 Østfold Akershus was founded in 1835 and is headquartered in Moss, Norway.
Earnings Per Share
As for profitability, SPBK1 ØSTFOLD AKE has a trailing twelve months EPS of kr38.29.
PE Ratio
SPBK1 ØSTFOLD AKE has a trailing twelve months price to earnings ratio of 9.25. Meaning, the purchaser of the share is investing kr9.25 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.1%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 34.7% and 17.7%, respectively.
Sales Growth
SPBK1 ØSTFOLD AKE’s sales growth for the next quarter is 7.3%.
Moving Average
SPBK1 ØSTFOLD AKE’s worth is above its 50-day moving average of kr335.31 and above its 200-day moving average of kr327.11.
More news about SPBK1 ØSTFOLD AKE.
